Gilead completes tender offer for Myogen
15th Nov 2006, 05:02 GMT
Biotechnology firm Gilead Sciences has reported the successful completion of its cash tender offer for all of the outstanding shares of common stock of Myogen.
Gilead completes tender offer for Myogen related news:
- Gilead Completes Tender Offer for Myogen — Operations-Related News from StratCenter.com
- Gilead Sciences Successfully Completes Tender Offer for Shares of Myogen With Over 91.3% of Shares Tendered — Operations-Related News from StratCenter.com
- Gilead Sciences schließt Übernahmeangebot für Aktien von Myogen mit über 91,3 Prozent gehandelten Aktien erfolgreich ab — Nachrichten Ticker - www.finanzen.net
- Abbott Begins Kos Tender Offer — Financial News News from StratCenter.com
- Abbott Labs Commences Tender Offer for All Outstanding Shares of Kos Pharmaceuticals — StratWire - Business of Healthcare NewsFeed
- Gilead Sciences hält am Freitag, den 17. November, eine Präsentation auf der Credit Suisse Healthcare Conference — Nachrichten Ticker - www.finanzen.net
- Life Sciences 25 — Boston Globe -- Business News
- RealNetworks Secures 99% of WiderThan Shares; Extends Subsequent Offering Period of Tender Offer — PR Newswire: All Releases
- Abbott Laboratories Commences Tender Offer for All Outstanding Shares of Kos Pharmaceuticals, Inc. — PR Newswire: All Releases
- RealNetworks extends tender offer for WiderThan shares — bizjournals.com High Tech:Networking headlines
Latest news from Pharmaceutical Business Review Latest News:
- Celesio revenues, profits up
- Amgen arthritis drug shows sustained safety and efficacy
- Study supports cardiovascular safety of naproxen
- Cangene chickenpox drug granted orphan status
- Reata brain cancer therapy shows strong activity
- Novartis diabetes drug faces three month delay
- Favrille drug fails secondary goal
- Neurogen commences human testing of obesity drug
- Aeterna prostate cancer drug shows promise
- Isis says new drug effective against cholesterol